Combined medical and surgical treatment of severe vernal keratoconjunctivitis

Hiroshi Fujishima, Kazumi Fukagawa, Yoshiyuki Satake, Ichiro Saito, Jun Shimazaki, Yoji Takano, Kazuo Tsubota

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Purpose: We report the efficacy of an alternative method of treatment for vernal keratoconjunctivitis (VKC) that consists of excision of the palpebral conjunctiva followed by supratarsal injection of corticosteroid and five times daily topical application of 0.05% cyclosporine A (CsA) and cromolyn sodium. Methods: We evaluated 10 patients with severe treat- resistant VKC with corneal complications. The patients were evaluated for symptoms and for signs, including conjunctival changes, corneal limbal infiltrates, vascularization, reduction of epitheliopathy, meibomitis, visual acuity, intraocular pressure, and pathologic evaluation, before and after treatment. Results: All patients showed marked improvement after 2 weeks of treatment. The symptoms (P < .01), signs (P < .02), and the visual acuity of all patients (P < .01) had significantly improved following treatment. Histological examination showed significant inflammatory cell decreases 4 weeks after surgery (P < .05). Conclusion: Surgery plus topical drug therapy may be useful in treating patients with very severe VKC. (C) 2000 Japanese Ophthalmological Society.

Original languageEnglish
Pages (from-to)511-515
Number of pages5
JournalJapanese Journal of Ophthalmology
Volume44
Issue number5
DOIs
Publication statusPublished - 2000 Sep

Fingerprint

Allergic Conjunctivitis
Visual Acuity
Therapeutics
Cromolyn Sodium
Conjunctiva
Intraocular Pressure
Cyclosporine
Signs and Symptoms
Adrenal Cortex Hormones
Drug Therapy
Injections

Keywords

  • Corneal complications
  • Cyclosporine A
  • Inflammatory cells
  • Surgical treatment
  • Vernal keratoconjunctivitis

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Combined medical and surgical treatment of severe vernal keratoconjunctivitis. / Fujishima, Hiroshi; Fukagawa, Kazumi; Satake, Yoshiyuki; Saito, Ichiro; Shimazaki, Jun; Takano, Yoji; Tsubota, Kazuo.

In: Japanese Journal of Ophthalmology, Vol. 44, No. 5, 09.2000, p. 511-515.

Research output: Contribution to journalArticle

Fujishima, H, Fukagawa, K, Satake, Y, Saito, I, Shimazaki, J, Takano, Y & Tsubota, K 2000, 'Combined medical and surgical treatment of severe vernal keratoconjunctivitis', Japanese Journal of Ophthalmology, vol. 44, no. 5, pp. 511-515. https://doi.org/10.1016/S0021-5155(00)00210-0
Fujishima, Hiroshi ; Fukagawa, Kazumi ; Satake, Yoshiyuki ; Saito, Ichiro ; Shimazaki, Jun ; Takano, Yoji ; Tsubota, Kazuo. / Combined medical and surgical treatment of severe vernal keratoconjunctivitis. In: Japanese Journal of Ophthalmology. 2000 ; Vol. 44, No. 5. pp. 511-515.
@article{83243734b56d4e87aa6a20b5e9f9157e,
title = "Combined medical and surgical treatment of severe vernal keratoconjunctivitis",
abstract = "Purpose: We report the efficacy of an alternative method of treatment for vernal keratoconjunctivitis (VKC) that consists of excision of the palpebral conjunctiva followed by supratarsal injection of corticosteroid and five times daily topical application of 0.05{\%} cyclosporine A (CsA) and cromolyn sodium. Methods: We evaluated 10 patients with severe treat- resistant VKC with corneal complications. The patients were evaluated for symptoms and for signs, including conjunctival changes, corneal limbal infiltrates, vascularization, reduction of epitheliopathy, meibomitis, visual acuity, intraocular pressure, and pathologic evaluation, before and after treatment. Results: All patients showed marked improvement after 2 weeks of treatment. The symptoms (P < .01), signs (P < .02), and the visual acuity of all patients (P < .01) had significantly improved following treatment. Histological examination showed significant inflammatory cell decreases 4 weeks after surgery (P < .05). Conclusion: Surgery plus topical drug therapy may be useful in treating patients with very severe VKC. (C) 2000 Japanese Ophthalmological Society.",
keywords = "Corneal complications, Cyclosporine A, Inflammatory cells, Surgical treatment, Vernal keratoconjunctivitis",
author = "Hiroshi Fujishima and Kazumi Fukagawa and Yoshiyuki Satake and Ichiro Saito and Jun Shimazaki and Yoji Takano and Kazuo Tsubota",
year = "2000",
month = "9",
doi = "10.1016/S0021-5155(00)00210-0",
language = "English",
volume = "44",
pages = "511--515",
journal = "Japanese Journal of Ophthalmology",
issn = "0021-5155",
publisher = "Springer Japan",
number = "5",

}

TY - JOUR

T1 - Combined medical and surgical treatment of severe vernal keratoconjunctivitis

AU - Fujishima, Hiroshi

AU - Fukagawa, Kazumi

AU - Satake, Yoshiyuki

AU - Saito, Ichiro

AU - Shimazaki, Jun

AU - Takano, Yoji

AU - Tsubota, Kazuo

PY - 2000/9

Y1 - 2000/9

N2 - Purpose: We report the efficacy of an alternative method of treatment for vernal keratoconjunctivitis (VKC) that consists of excision of the palpebral conjunctiva followed by supratarsal injection of corticosteroid and five times daily topical application of 0.05% cyclosporine A (CsA) and cromolyn sodium. Methods: We evaluated 10 patients with severe treat- resistant VKC with corneal complications. The patients were evaluated for symptoms and for signs, including conjunctival changes, corneal limbal infiltrates, vascularization, reduction of epitheliopathy, meibomitis, visual acuity, intraocular pressure, and pathologic evaluation, before and after treatment. Results: All patients showed marked improvement after 2 weeks of treatment. The symptoms (P < .01), signs (P < .02), and the visual acuity of all patients (P < .01) had significantly improved following treatment. Histological examination showed significant inflammatory cell decreases 4 weeks after surgery (P < .05). Conclusion: Surgery plus topical drug therapy may be useful in treating patients with very severe VKC. (C) 2000 Japanese Ophthalmological Society.

AB - Purpose: We report the efficacy of an alternative method of treatment for vernal keratoconjunctivitis (VKC) that consists of excision of the palpebral conjunctiva followed by supratarsal injection of corticosteroid and five times daily topical application of 0.05% cyclosporine A (CsA) and cromolyn sodium. Methods: We evaluated 10 patients with severe treat- resistant VKC with corneal complications. The patients were evaluated for symptoms and for signs, including conjunctival changes, corneal limbal infiltrates, vascularization, reduction of epitheliopathy, meibomitis, visual acuity, intraocular pressure, and pathologic evaluation, before and after treatment. Results: All patients showed marked improvement after 2 weeks of treatment. The symptoms (P < .01), signs (P < .02), and the visual acuity of all patients (P < .01) had significantly improved following treatment. Histological examination showed significant inflammatory cell decreases 4 weeks after surgery (P < .05). Conclusion: Surgery plus topical drug therapy may be useful in treating patients with very severe VKC. (C) 2000 Japanese Ophthalmological Society.

KW - Corneal complications

KW - Cyclosporine A

KW - Inflammatory cells

KW - Surgical treatment

KW - Vernal keratoconjunctivitis

UR - http://www.scopus.com/inward/record.url?scp=0033780922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033780922&partnerID=8YFLogxK

U2 - 10.1016/S0021-5155(00)00210-0

DO - 10.1016/S0021-5155(00)00210-0

M3 - Article

VL - 44

SP - 511

EP - 515

JO - Japanese Journal of Ophthalmology

JF - Japanese Journal of Ophthalmology

SN - 0021-5155

IS - 5

ER -